Cynthia Omoge Akagbosu

Dr. Cynthia Omoge Akagbosu

Pediatric Gastroenterology, Children's National Hospital, Washington, District of Columbia, USA
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2019 in MedEdPORTAL
Verified
Journal Article
Closed access
JPJoanna Perdomo
Joanna Perdomo
DTDestiny Tolliver
Destiny Tolliver
HHHeather Hsu
Heather Hsu
YHYuan He
Yuan He
KNKatherine A. Nash
Katherine A. Nash
CMCatherine D. Michelson
Catherine D. Michelson
The medical community recognizes the importance of confronting structural racism and implicit bias to address health inequities. Several curricula aimed at teaching trainees about these issues are described in the literature. However, few curricula exist that engage faculty members as learners rather than teachers of these topics or target interdisciplinary audiences. We developed a longitudinal case conference curriculum called Health Equity Rounds (HER) to discuss and address the impact of structural racism and implicit bias on patient care. The curriculum engaged participants across training levels and disciplines on these topics utilizing case-based discussion, evidence-based exercises, and two relevant conceptual frameworks. It was delivered quarterly as part of a departmental case conference series. We evaluated HER's feasibility and acceptability by tracking conference attendance and administering postconference surveys. We analyzed quantitative survey data using descriptive statistics and qualitatively reviewed free-text comments. We delivered seven 1-hour HER conferences at our institution from June 2016 to June 2018. A mean of 66 participants attended each HER. Most survey respondents (88% or more) indicated that HER promoted personal reflection on implicit bias, and 75% or more indicated that HER would impact their clinical practice. HER provided a unique forum for practitioners across training levels to address structural racism and implicit bias. Our aim in dissemination is to provide meaningful tools for others to adapt at their own institutions, recognizing that HER should serve as a component of larger, multifaceted efforts to decrease structural racism and implicit bias in health care.

20 December 2010 in Schizophrenia Bulletin
Verified
Journal Article
Open access
PDF file
Cynthia Omoge AkagbosuCynthia Omoge Akagbosu
Cynthia Omoge Akagbosu
GEGretchen C. Evans
Gretchen C. Evans
DGDanielle Gulick
Danielle Gulick
RSRaymond F. Suckow
Raymond F. Suckow
DBDavid J. Bucci
David J. Bucci
The glia-derived molecule kynurenic acid (KYNA) is an antagonist of α7 nicotinic acetylcholine receptors and the glycineB binding site on n-methyl-d-aspartateglutamate receptors, both of which have critical roles in neural plasticity as well as learning and memory. KYNA levels are increased in the brains and cerebral spinal fluid of persons with schizophrenia, leading to the notion that changes in KYNA concentration might contribute to cognitive dysfunction associated with this disorder. Indeed, recent studies indicate that increasing endogenous KYNA concentration by administering l-kynurenine (L-KYN, the precursor of KYNA) impairs spatial as well as contextual learning and memory in adult rats. In the present study, rats were treated with L-KYN (100 mg/kg) throughout adolescence to increase endogenous KYNA concentration during this critical time in brain development. Rats were then tested drug-free as adults to test the hypothesis that exposure to elevated levels of KYNA during development may contribute to cognitive dysfunction later in life. Consistent with prior studies in which adult rats were treated acutely with L-KYN, juvenile rats exposed to increased KYNA concentration during adolescence exhibited deficits in contextual fear memory, but cue-specific fear memory was not impaired. In addition, rats treated with L-KYN as adolescents were impaired on a novel object recognition memory task when tested as adults. The memory deficits could not be explained by drug-induced changes in locomotor activity or shock sensitivity. Together, these findings add to the growing literature supporting the notion that exposure to increased concentration of KYNA may contribute to cognitive deficits typically observed in schizophrenia.

Verified
Journal Article
Open access
PDF file
Cynthia Omoge AkagbosuCynthia Omoge Akagbosu
Cynthia Omoge Akagbosu
ENEvan P. Nadler
Evan P. Nadler
SLShira Levy
Shira Levy
SHSuchitra K Hourigan
Suchitra K Hourigan
Obesity affects 42.4% of adults and 19.3% of children in the United States. Childhood obesity drives many comorbidities including hypertension, fatty liver disease, and type 2 diabetes mellitus. Prior research suggests that aberrant compositional development of the gut microbiome, with low-grade inflammation, precedes being overweight. Therefore, childhood may provide opportunities for interventions that shape the microbiome to mitigate obesity-related diseases. Children with obesity have gut microbiota compositional and functional differences, including increased proinflammatory bacterial taxa, compared to lean controls. Restoration of the gut microbiota to a healthy state may ameliorate conditions associated with obesity and help maintain a healthy weight. Pediatric bariatric (weight-loss) surgery is an effective treatment for childhood obesity; however, there is limited research into the role of the gut microbiome after weight-loss surgery in children. This review will discuss the magnitude of childhood obesity, the importance of the developing microbiome in establishing metabolic pathways, interventions such as bariatric surgery that may modulate the gut microbiome, and future directions for the potential development of microbiome-based therapeutics to treat obesity.

1 February 2015 in Stroke
Verified
Journal Article
Closed access
Cynthia Omoge AkagbosuCynthia Omoge Akagbosu
Cynthia Omoge Akagbosu
ASArmide Storey
Armide Storey
RRRichard Robertson
Richard Robertson
RSR. Michael Scott
R. Michael Scott
ESEdward Smith
Edward Smith
Introduction: The prevalence of angiographically evident pre-operative transdural collaterals to the brain in moyamoya is not well documented. Hypothesis: We hypothesized that presence of transdural collaterals would be associated with more advanced moyamoya disease at diagnosis, more frequent operative complications and better long-term angiographic results. Methods: Single institution case series reviewing all moyamoya patients with 6 vessel arteriograms treated surgically from 2005-2013. Results: 204 patients (n=121 (59%) F / 83 (41%) M) were diagnosed with moyamoya at 9.5 years of age (range 0.4-35 years). Presentation included ischemia (84% stroke or TIA), headache (36%), incidental (7%), chorea (3%) and hemorrhage (1%). Radiographically, 154 (75%) had bilateral disease for a total of 358 affected hemispheres, 152 (75%) had radiographic stroke and 190 (93%) had ivy sign on FLAIR MRI, indicating slow flow. Of the 358 hemispheres, 324 were treated operatively. On preoperative angiogram, 99 patients (49%) had transdural collaterals in 174 affected hemispheres (54%). Suzuki grades were higher in patients with collaterals (3.4 vs. 3.0, p=0.002). Of a total of 324 treated hemispheres, 84 (26%) had collaterals within the area of the surgical field. Complications included 12 strokes (3.7% stroke rate per hemisphere), with 5 (42%) directly attributable to interruption of a transdural collateral. In one-year postoperative arteriograms in 215 hemispheres, while not significant, Matsushima grades trended better in patients with preoperative collaterals, (1.6 vs. 1.8; A=1, B=2, C=3, p=0.09). Conclusions: In conclusion, transdural collaterals are present in nearly half of all moyamoya patients. They are more common in advanced disease, are associated with stroke as a perioperative complication and may suggest increased capacity to produce surgical collaterals postoperatively. These data support the utility of preoperative arteriograms.